Literature DB >> 8460482

Enrichment of insertional mutants following retrovirus gene trap selection.

W Chang1, S C Hubbard, C Friedel, H E Ruley.   

Abstract

The present study has investigated the use of gene trap retroviruses as insertional mutagens. A gene trap vector (U3Hygro) was used to target single-copy thymidine kinase (tk) genes, present at different sites in the genome. Cell populations isolated by gene trap selection contained a higher proportion of insertional mutants as compared with nonselected cells containing randomly integrated viruses. The number of integration events required to observe loss of gene function was reduced from 8-40 x 10(6) to 2-10 x 10(4), an overall enrichment of 100- to 1000-fold. The feasibility of targeting normally diploid genes was also demonstrated in hypodiploid Chinese hamster ovary cells. The cellular gene encoding GlcNAc transferase I was disrupted in one wheat germ agglutinin resistant clone selected from a total of 5 x 10(4) gene trap events. The clone was nullizygous for GlcNAc transferase I, indicating that the allele opposite the provirus was lost as a result of preexisting hemizygosity or by loss of heterozygosity. Finally, the total number of genes in the genome that could activate the expression of retrovirus gene traps was estimated at between 2 x 10(4) and 10(5), suggesting that most expressed genes can be mutagenized by gene trap selection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8460482     DOI: 10.1006/viro.1993.1182

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Gene trap insertional mutagenesis in mice: new vectors and germ line mutations in two novel genes.

Authors:  E G Neilan; G S Barsh
Journal:  Transgenic Res       Date:  1999       Impact factor: 2.788

2.  Activation of cryptic 3' splice sites within introns of cellular genes following gene entrapment.

Authors:  Anna B Osipovich; Erica K White-Grindley; Geoffrey G Hicks; Michael J Roshon; Christian Shaffer; Jason H Moore; H Earl Ruley
Journal:  Nucleic Acids Res       Date:  2004-05-20       Impact factor: 16.971

Review 3.  Functional genomics of the murine immune system.

Authors:  H E Ruley
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

4.  Post-entrapment genome engineering: first exon size does not affect the expression of fusion transcripts generated by gene entrapment.

Authors:  Anna B Osipovich; Aparna Singh; H Earl Ruley
Journal:  Genome Res       Date:  2005-03       Impact factor: 9.043

5.  Self-deleting retrovirus vectors for gene therapy.

Authors:  A P Russ; C Friedel; M Grez; H von Melchner
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  Isolation and characterization of a Chinese hamster ovary mutant cell line with altered sensitivity to vaccinia virus killing.

Authors:  C H Bair; C S Chung; I A Vasilevskaya; W Chang
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

7.  Cre/lox generation of a novel whole-body Kiss1r KO mouse line recapitulates a hypogonadal, obese, and metabolically-impaired phenotype.

Authors:  Kristen P Tolson; Nuha Marooki; Andrew Wolfe; Jeremy T Smith; Alexander S Kauffman
Journal:  Mol Cell Endocrinol       Date:  2019-08-20       Impact factor: 4.102

8.  Characterization of a Chinese hamster ovary cell line developed by retroviral insertional mutagenesis that is resistant to Sindbis virus infection.

Authors:  J T Jan; A P Byrnes; D E Griffin
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

9.  Identification of genes induced by factor deprivation in hematopoietic cells undergoing apoptosis using gene-trap mutagenesis and site-specific recombination.

Authors:  A P Russ; C Friedel; K Ballas; U Kalina; D Zahn; K Strebhardt; H von Melchner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

10.  A replication-competent promoter-trap retrovirus.

Authors:  J Coulombe; Y Avis; D A Gray
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.